Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Yau

Showing results (131-140 of 133) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 133 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 27, 2023
Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040A B El-Khoueiry, J Trojan, T Meyer, et al.
Obesity Research & Clinical Practice|September 25, 2021
The relationship between visceral adiposity and cardiometabolic risk in Chinese women with polycystic ovary syndromeN Y H Ng, K H Liu, C H T Tam, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 6, 2024
Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040I Melero, T Yau, Y-K Kang, et al.
Pageof 14

Showing results (131-140 of 133) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 133 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 27, 2023
Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040A B El-Khoueiry, J Trojan, T Meyer, et al.
Obesity Research & Clinical Practice|September 25, 2021
The relationship between visceral adiposity and cardiometabolic risk in Chinese women with polycystic ovary syndromeN Y H Ng, K H Liu, C H T Tam, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 6, 2024
Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040I Melero, T Yau, Y-K Kang, et al.
Pageof 14